HIGHLIGHTS
- who: Qi Li from the Department of Pathology, The Third Affiliated Hospital of Jinzhou Medical University, Jinzhou, China have published the article: Myricetin Suppresses Ovarian Cancer In Vitro by Activating the p38/Sapla Signaling Pathway and Suppressing Intracellular Oxidative Stress, in the Journal: (JOURNAL)
- what: The authors investigated the effect of myricetin on ovarian cancer cells, and whether its effects were mediated by p38/Sapla signaling pathway. The results of this study provide a theoretical basis for the development of myricetin-based drugs for cancer treatment.
- how: Cell Migration Assay A wound-healing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.